Bio/Pharma News

Adaptimmune and Universal Cells Collaborate to Develop Allogeneic T-Cell Therapies

December 04, 2015

Adaptimmune Therapeutics and Universal Cells enter into collaboration and license agreement to develop universal allogeneic T-cell therapies.

Paragon Bioservices to Develop HIV Vaccine Candidate

December 04, 2015

PTSM: Pharmaceutical Technology Sourcing and Management

Paragon Bioservices entered into a contract with the International Aids Vaccine Initiative for the process and analytical development and cGMP manufacturing of an HIV vaccine candidate.

Seqirus Opens Corporate Headquarters in the United Kingdom

December 03, 2015

Seqirus, CSL Limited’s influenza vaccine business, announced the opening of their corporate headquarters in the United Kingdom.

Amgen's Biosimilar BLA For ABP 501 Submitted To FDA

December 01, 2015

Amgen announced the submission of a BLA with the FDA for ABP 501.

Paras Biopharmaceuticals and Novozymes Set to Collaborate on Osteoporosis Treatment

November 30, 2015

Paras Biopharmaceuticals and Novozymes will collaborate on the creation of an improved osteoporosis treatment.

Novo Nordisk to Switch to Renewable Energy by 2020

November 26, 2015

The goal is to have all of Novo Nordisk’s production plants operating on renewable electricity with zero CO2 emissions by 2020.

Hikma Sells Ben Venue Manufacturing Facilities to Xellia

November 26, 2015

Under the terms of the agreement, Xellia will acquire substantial parts of the Ben Venue site, including four sterile injectable manufacturing plants, which are not currently operational.

Pfizer-Allergan Merger Valued at $160 Billion

November 23, 2015

The proposed merger of Pfizer and Allergan will create a new top drug maker and cut Pfizer’s tax bill with a headquarters move to Ireland.

Charles River Laboratories Acquires Oncotest GmbH

November 19, 2015

Charles River Laboratories announces the acquisition of Oncotest GmbH.

FDA Approves Darzalex

November 16, 2015